Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence
Tobacco use is the top preventable cause of early mortality in schizophrenia. Over 60% of people with schizophrenia smoke, three times the general prevalence. The biological basis of this increased risk is not understood, and existing interventions do not target schizophrenia-specific pathology. We...
Main Authors: | Beermann, A. (Author), Brady, R.O., Jr (Author), Halko, M.A (Author), Janes, A.C (Author), Moran, L.V (Author), Nawaz, U. (Author), Ward, H.B (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Prevalence and patterns of tobacco use and nicotine dependence among males industrial workers
by: K J Divinakumar, et al.
Published: (2017-01-01) -
Editorial: New Insights on Basic and Clinical Aspects of EEG and MEG Connectome
by: Ryouhei Ishii, et al.
Published: (2018-06-01) -
Provision of free nicotine replacement therapy to parental smokers in the pediatric emergency setting
by: E. Melinda Mahabee-Gittens, et al.
Published: (2020-05-01) -
A Comparison of Dependence across Different Types of Nicotine Containing Products and Coffee
by: Karl Fagerstrom
Published: (2018-07-01) -
Integration of the Existed Knowledge on DMN: A Critical Review Study
by: Hoda Purrezaian, et al.
Published: (2019-01-01)